COVID-19 may soon be treatable with a pill.
In the past six weeks, two drugmakers have announced promising clinical trial results for their experimental oral antiviral pills and will soon have their data evaluated by the Food and Drug Administration (FDA).
The first drug comes from Merck, which collaborated with Ridgeback Biotherapeutics on a medication called molnupiravir, an antiviral originally developed to treat flu viruses. An FDA advisory committee is set to meet Nov. 30 to discuss the companies’ request for emergency use authorization. And last week, Pfizer announced the results of its clinical trial of the antiviral Paxlovid and said it would submit its data to the FDA in the coming weeks.
Please select this link to read the complete article from NBC News.